Human parvovirus B19 infection in an immunocompromised host

Abstract

Abstract Serologic testing may be negative in immunocompromised hosts due to inadequate IgG and IgM response. The classic bone marrow findings of viral inclusions and giant proerythroblasts are pathognomonic for active infection and should prompt initiation of therapy regardless of serologic results.

Keywords

• bone marrow morphology
• diagnosis
• parvovirus B19 infection
• treatment